Yimei Li Selected Research

Radiotherapy

12/2022	Endocrine outcomes after limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: Long-term results from the RT1 protocol.
12/2022	Limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: long-term results from the RT1 protocol.
7/2022	Image-based data mining applies to data collected from children.
5/2022	Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
1/2022	Pre- and Posttherapy Risk Factors for Vasculopathy in Pediatric Patients With Craniopharyngioma Treated With Surgery and Proton Radiation Therapy.
1/2022	Carboplatin During Craniospinal Radiotherapy for Children With Group 3 Medulloblastoma-A New Standard of Care?-Reply.
1/2021	Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
1/2021	Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
1/2021	A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.
3/2020	Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yimei Li Research Topics

Disease

41	Neoplasms (Cancer) 12/2022 - 01/2012
15	Neuroblastoma 05/2022 - 01/2013
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2013
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2014
10	Leukemia 01/2022 - 04/2013
9	Medulloblastoma 01/2022 - 04/2012
8	Craniopharyngioma (Craniopharyngiomas) 12/2022 - 09/2015
7	Brain Neoplasms (Brain Tumor) 07/2022 - 04/2012
5	Pain (Aches) 01/2022 - 01/2018
5	Infections 09/2015 - 04/2010
4	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2019
4	Glioma (Gliomas) 01/2022 - 04/2012
4	Diffuse Intrinsic Pontine Glioma 03/2020 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2013
3	Neutropenia 10/2021 - 12/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 02/2018
3	Sickle Cell Anemia (Hemoglobin S Disease) 11/2017 - 01/2012
2	Lymphoma (Lymphomas) 10/2021 - 06/2012
2	Fever (Fevers) 10/2021 - 12/2014
2	Malnutrition (Nutritional Deficiencies) 04/2020 - 02/2018
2	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 04/2012
2	Human Influenza (Influenza) 12/2015 - 01/2012
2	Cysts 09/2015 - 09/2011
2	Cardiotoxicity 04/2015 - 04/2013
2	Sepsis (Septicemia) 02/2014 - 06/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2013 - 03/2013
2	Anaphylaxis (Anaphylactic Shock) 07/2012 - 09/2011
1	Hypothyroidism 12/2022
1	Diabetes Insipidus 12/2022
1	Disease Resistance 10/2022
1	Graves Disease (Basedow Disease) 03/2022
1	Acute Pain 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Neurofibromatoses (Neurofibromatosis) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Cataract (Cataracts) 01/2022
1	Intractable Pain 11/2021
1	Hypoxia (Hypoxemia) 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2021
1	Acute Lung Injury 10/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Cytokine Release Syndrome 10/2021
1	Bacteremia 10/2021

Drug/Important Bio-Agent (IBA)

6	Protons (Proton)IBA 07/2022 - 02/2018
6	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
5	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2013
5	dipinacoline glutamateIBA 03/2020 - 05/2014
4	tisagenlecleucelIBA 01/2022 - 10/2021
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2018
2	Growth Hormone (Somatotropin)IBA 01/2022 - 01/2020
2	Isotretinoin (Accutane)FDA LinkGeneric 09/2021 - 10/2018
2	EpitopesIBA 01/2021 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 04/2017
2	GlucocorticoidsIBA 01/2019 - 01/2018
2	RacivirIBA 01/2018 - 11/2015
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2016
2	ribociclibIBA 04/2017 - 11/2013
2	AntigensIBA 05/2015 - 09/2011
2	AnthracyclinesIBA 04/2015 - 04/2013
2	Dexrazoxane (Zinecard)FDA LinkGeneric 04/2015 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 10/2013 - 01/2002
2	VaccinesIBA 01/2012 - 04/2010
1	Hormones (Hormone)IBA 12/2022
1	Dihydrotachysterol (AT 10)IBA 12/2022
1	GTP-Binding Proteins (G-Protein)IBA 10/2022
1	Thyroid HormonesIBA 03/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	CeramidesIBA 01/2022
1	CD19-specific chimeric antigen receptorIBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 11/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2021
1	tocilizumab (atlizumab)FDA Link 10/2021
1	CytokinesIBA 10/2021
1	rhodiolosideIBA 10/2021

Therapy/Procedure

37	Therapeutics 05/2022 - 08/2009
28	Drug Therapy (Chemotherapy) 05/2022 - 04/2012
24	Radiotherapy 12/2022 - 06/2013
7	Proton Therapy 03/2022 - 09/2015
5	Cell Transplantation 07/2021 - 11/2017
4	Aftercare (After-Treatment) 12/2022 - 09/2012
4	Induction Chemotherapy 05/2022 - 03/2013
4	Transplantation 01/2022 - 01/2019
4	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2013
4	Critical Care (Surgical Intensive Care) 01/2018 - 02/2014
3	Length of Stay 01/2019 - 10/2014
2	Maintenance Chemotherapy 05/2022 - 10/2021
2	Craniospinal Irradiation 01/2021 - 04/2012
2	Retreatment 01/2021 - 01/2020
2	Adjuvant Chemotherapy 01/2021 - 12/2019
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 11/2021
1	Treatment Delay 10/2021